Antimicrobial Agents Practice Questions

Q: Which of the following statements about cephalosporins is false?

Cefoxitin has no activity against anaerobes.. ***Cefoxitin has no activity against anaerobes.*** - This statement is **false** because **cefoxitin** is a second-generation cephalosporin known for its **excellent activity against anaerobic bacteria**, particularly *Bacteroides fragilis*. - Its anaerobic coverage makes it useful for treating infections where these organisms are suspected, such as intra-abdominal and pelvic infections. *Ceftazidime is a 3rd generation cephalosporin.* - This statement is **true**. **Ceftazidime** is a third-generation cephalosporin characterized by its broad-spectrum activity, including significant coverage against **Pseudomonas aeruginosa**. - Its primary clinical utility is often in treating difficult Gram-negative infections. *Cefoperazone has got antipseudomonal effect.* - This statement is **true**. **Cefoperazone** is a third-generation cephalosporin that exhibits **antipseudomonal activity**, similar to ceftazidime. - It is often used for treating infections caused by **Pseudomonas aeruginosa** and other difficult Gram-negative bacteria. *Cephalosporins act by inhibiting cell wall synthesis.* - This statement is **true**. Like other beta-lactam antibiotics, **cephalosporins** exert their bactericidal effect by **inhibiting bacterial cell wall synthesis**. - They bind to and inactivate **penicillin-binding proteins (PBPs)**, which are essential enzymes involved in peptidoglycan cross-linking, leading to compromised cell wall integrity and bacterial lysis.

Q: Which of the following drugs does not inhibit protein synthesis?

Beta-lactam antibiotics. ***Beta-lactam antibiotics*** - **Beta-lactam antibiotics** (e.g., penicillin, cephalosporins) primarily inhibit bacterial **cell wall synthesis** by interfering with penicillin-binding proteins (PBPs) [1, 2]. - This mechanism is distinct from inhibiting protein synthesis, as they target the structural integrity of the bacterial cell rather than its metabolic machinery for protein production [1].*Tetracycline* - **Tetracyclines** bind to the **30S ribosomal subunit** of bacteria, preventing the attachment of aminoacyl-tRNA [3]. - This action directly inhibits the elongation of the polypeptide chain during protein synthesis, making it a protein synthesis inhibitor [3].*Chloramphenicol* - **Chloramphenicol** binds to the **50S ribosomal subunit**, specifically inhibiting the **peptidyl transferase** activity. - This prevents the formation of peptide bonds between amino acids, thereby blocking protein synthesis.*Erythromycin* - **Erythromycin**, a macrolide antibiotic, binds to the **50S ribosomal subunit** of bacteria. - It inhibits translocation, the process by which the ribosome moves along the mRNA, effectively halting protein synthesis.

Q: Which of the following drugs is an antipseudomonal penicillin?

Piperacillin. ***Piperacillin*** - **Piperacillin** is a broad-spectrum **antipseudomonal penicillin** (ureidopenicillin) that has significant activity against **Pseudomonas aeruginosa** due to modifications in its side chains. - It works by inhibiting bacterial cell wall synthesis and is often combined with a beta-lactamase inhibitor like **tazobactam** to broaden its spectrum further and overcome resistance. *Amoxicillin* - **Amoxicillin** is an **aminopenicillin** with a broader spectrum than natural penicillins, covering many gram-positive and gram-negative bacteria. - However, it **lacks antipseudomonal activity** and is not effective against **Pseudomonas aeruginosa**. - It does not have the structural modifications required for activity against Pseudomonas species. *Dicloxacillin* - **Dicloxacillin** is an **anti-staphylococcal penicillin** (penicillinase-resistant penicillin) primarily used for infections caused by methicillin-susceptible *Staphylococcus aureus*. - It does not have significant activity against **Pseudomonas aeruginosa** or other gram-negative organisms. *Cloxacillin* - **Cloxacillin** is similar to dicloxacillin, belonging to the **penicillinase-resistant penicillins**, and is used to treat infections caused by *Staphylococcus aureus*. - It lacks the necessary structural modifications to be effective against **Pseudomonas aeruginosa**.

Q: What is the primary advantage of the newer liposomal preparation of amphotericin B?

Reduced nephrotoxicity.. ***Reduced nephrotoxicity*** - The liposomal formulation encapsulates **amphotericin B**, reducing its direct interaction with renal tubular cells. - This encapsulation minimizes the drug's impact on kidney function, which is a major dose-limiting toxicity of conventional amphotericin B. *Similar efficacy and antifungal spectrum as conventional preparations* - While maintaining efficacy is a goal, the primary advantage of liposomal amphotericin B is its **improved safety profile**, specifically reduced toxicity. - The efficacy and spectrum are generally comparable to the conventional form, but this is not the main reason for its development or preference. *Lower tissue uptake in the kidneys* - This statement is partially true in that the liposomal formulation is designed to **reduce drug accumulation specifically in the kidneys**, which contributes to lower nephrotoxicity. - However, the most direct and crucial advantage is the resulting *reduction in nephrotoxicity* itself, rather than just the mechanism of lower uptake. *All of the above* - This option is incorrect because while liposomal amphotericin B does have similar efficacy and reduced kidney uptake, the overarching primary advantage that makes it clinically superior is the **significantly reduced nephrotoxicity**.

Q: Which one of the following statements is false regarding the use of adefovir dipivoxil?

It is used as a first-line treatment for HIV.. ***It is used as a first-line treatment for HIV.*** - **Adefovir dipivoxil** is primarily indicated for the treatment of **chronic hepatitis B** infection, not HIV [1]. - While it has some *in vitro* activity against HIV, it is **not recommended** for HIV treatment due to its suboptimal efficacy and potential for **nephrotoxicity** at the higher doses required for HIV [2]. *It is generally well tolerated when taken orally.* - **Adefovir dipivoxil** is indeed generally **well-tolerated** at the doses used for hepatitis B, with common side effects being mild and transient [2]. - However, **higher doses** can lead to significant **nephrotoxicity**, which is why it's not preferred for HIV treatment [2]. *It is an acyclic nucleotide analogue.* - **Adefovir dipivoxil** is a **prodrug** of adefovir, which is an **acyclic nucleotide analogue** (specifically, an adenosine monophosphate analogue) [1]. - This structure allows it to mimic natural nucleotides and interfere with **viral reverse transcriptase** or **DNA polymerase** [1]. *It is effective in treating chronic hepatitis B infection.* - **Adefovir dipivoxil** is an **antiviral medication** specifically approved and effective in treating **chronic hepatitis B virus (HBV) infection** [1]. - It works by inhibiting HBV DNA polymerase, thereby reducing **viral replication** [1].

Q: What is an example of an entry inhibitor?

Enfuvirtide. ***Enfuvirtide*** - **Enfuvirtide** is a **fusion inhibitor** that blocks **HIV-1** from entering target cells by binding to the gp41 subunit of the viral envelope glycoprotein. - It works by preventing the conformational change in gp41 required for fusion of the viral and cellular membranes. *Abacavir* - **Abacavir** is a **nucleoside reverse transcriptase inhibitor (NRTI)**. - NRTIs incorporate into the growing viral DNA chain, causing chain termination and preventing viral replication. *Etravirine* - **Etravirine** is a **non-nucleoside reverse transcriptase inhibitor (NNRTI)**. - NNRTIs bind directly to the reverse transcriptase enzyme, altering its structure and inhibiting its function. *Amprenavir* - **Amprenavir** is a **protease inhibitor (PI)**. - Protease inhibitors prevent the cleavage of viral polyproteins into functional proteins, which is essential for the assembly of new infectious virions.

Q: Which antibiotic should not be taken with milk?

Tetracycline. ***Tetracycline*** - **Tetracycline** forms **insoluble chelates** with divalent and trivalent cations such as calcium (in milk), iron, magnesium, and aluminum. - This chelation significantly **reduces the absorption** of tetracycline from the gastrointestinal tract, diminishing its effectiveness. *Chloramphenicol* - **Chloramphenicol** absorption is generally not significantly affected by milk or food intake. - It is known for its potential to cause **bone marrow suppression** and **aplastic anemia**, unrelated to milk interactions. *Erythromycin* - Some forms of **erythromycin** (e.g., erythromycin stearate) are better absorbed on an empty stomach, but milk itself does not typically form insoluble complexes that drastically reduce absorption like with tetracyclines. - It can cause gastrointestinal side effects like **nausea** and **abdominal cramps**. *Sulfonamide* - **Sulfonamides** are generally well-absorbed and their absorption is not significantly impacted by milk. - They are known for potential side effects such as **allergic reactions** and **crystalluria**.

Q: Ketoconazole is useful in all except:

T. capitis. ***T. capitis*** - **Ketoconazole** is generally not considered the first-line or most effective treatment for **Tinea capitis** due to its poor penetration into hair follicles. - **Oral griseofulvin** or **terbinafine** are preferred systemic antifungals for **Tinea capitis** because they can reach the infected hair shafts more effectively. *T. cruris* - **Ketoconazole** is an effective antifungal for **Tinea cruris**, which is a fungal infection of the groin, as it can be applied topically. - Its broad-spectrum antifungal activity makes it suitable for treating various superficial dermatophyte infections. *T. versicolor* - **Ketoconazole** is highly effective in treating **Tinea versicolor** (also known as Pityriasis versicolor), a superficial fungal infection caused by *Malassezia* species. - It can be used both topically (shampoo, cream) and orally to reduce the fungal burden. *T. corporis* - **Ketoconazole** is an appropriate topical antifungal agent for **Tinea corporis**, commonly known as ringworm of the body. - Its ability to inhibit ergosterol synthesis makes it effective against the dermatophytes responsible for this infection.

Q: The drug that should be used for prophylaxis of close contacts of a patient suffering from meningococcal meningitis is:

Rifampicin. ***Rifampicin*** - **Rifampicin** is a primary agent for meningococcal prophylaxis due to its ability to eliminate carriage of *Neisseria meningitidis* from the nasopharynx. - It is effective, given orally, and reaches high concentrations in respiratory secretions. *Erythromycin* - While **erythromycin** is an antibiotic, it is not the preferred drug for **meningococcal prophylaxis** because it is less effective at eradicating nasopharyngeal carriage of *N. meningitidis* compared to rifampicin. - It also has a broader spectrum and higher potential for gastrointestinal side effects when used for prophylaxis. *Amikacin* - **Amikacin** is an aminoglycoside antibiotic primarily used for severe Gram-negative bacterial infections and is typically administered intravenously. - It is not effective for meningococcal prophylaxis as it does not adequately penetrate the nasopharynx and is not active against **meningococci** in this context. *Dapsone* - **Dapsone** is an antibacterial drug primarily used for the treatment of leprosy and dermatitis herpetiformis, as well as *Pneumocystis jirovecii* pneumonia prophylaxis in immunocompromised individuals. - It has no role in the prophylaxis or treatment of **meningococcal meningitis**.

Q: Which of the following drugs used in anti-tubercular therapy is a potent bactericidal agent that inhibits RNA synthesis?

Rifampicin. ***Rifampicin*** - **Rifampicin** is a potent **bactericidal** anti-tubercular drug that inhibits bacterial **RNA synthesis** by binding to DNA-dependent RNA polymerase. - It is effective against both **rapidly dividing** and **metabolically active** *M. tuberculosis* strains. - Among first-line anti-TB drugs, it is considered the most potent bactericidal agent with sterilizing activity. *Pyrazinamide* - **Pyrazinamide** is **bactericidal** against **intracellular** and **slowly replicating** *M. tuberculosis* in acidic environments. - Its mechanism involves disrupting **mycobacterial membrane metabolism** and **transport functions** under acidic conditions, not RNA synthesis. - It has unique sterilizing activity against dormant bacilli. *Ethambutol* - **Ethambutol** is primarily **bacteriostatic**, inhibiting the synthesis of the **mycobacterial cell wall** by interfering with arabinosyl transferases. - It prevents the formation of **arabinogalactan**, an essential component of the mycobacterial cell wall. *PAS* - **Para-aminosalicylic acid (PAS)** is a **bacteriostatic** drug that inhibits **folic acid synthesis** in *M. tuberculosis*, similar to sulfonamides. - It is a **second-line agent** used primarily in cases of drug resistance.

Question 1

Which of the following statements about cephalosporins is false?

Accepted Answer

Cefoxitin has no activity against anaerobes.

Answer

Cefoperazone has got antipseudomonal effect.

Answer

Cephalosporins act by inhibiting cell wall synthesis.

Answer

Ceftazidime is a 3rd generation cephalosporin.

Question 2

Which of the following drugs does not inhibit protein synthesis?

Accepted Answer

Beta-lactam antibiotics

Answer

Tetracycline

Answer

Chloramphenicol

Answer

Erythromycin

Question 3

Which of the following drugs is an antipseudomonal penicillin?

Accepted Answer

Piperacillin

Answer

Amoxicillin

Answer

Dicloxacillin

Answer

Cloxacillin

Question 4

What is the primary advantage of the newer liposomal preparation of amphotericin B?

Accepted Answer

Reduced nephrotoxicity.

Answer

Lower tissue uptake in the kidneys.

Answer

Similar efficacy and antifungal spectrum as conventional preparations.

Answer

All of the above

Question 5

Which one of the following statements is false regarding the use of adefovir dipivoxil?

Accepted Answer

It is used as a first-line treatment for HIV.

Answer

It is generally well tolerated when taken orally.

Answer

It is an acyclic nucleotide analogue.

Answer

It is effective in treating chronic hepatitis B infection.

Question 6

What is an example of an entry inhibitor?

Accepted Answer

Enfuvirtide

Answer

Abacavir

Answer

Amprenavir

Answer

Etravirine

Question 7

Which antibiotic should not be taken with milk?

Accepted Answer

Tetracycline

Answer

Chloramphenicol

Answer

Erythromycin

Answer

Sulfonamide

Question 8

Ketoconazole is useful in all except:

Accepted Answer

T. capitis

Answer

T. cruris

Answer

T. versicolor

Answer

T. corporis

Question 9

The drug that should be used for prophylaxis of close contacts of a patient suffering from meningococcal meningitis is:

Accepted Answer

Rifampicin

Answer

Amikacin

Answer

Erythromycin

Answer

Dapsone

Question 10

Which of the following drugs used in anti-tubercular therapy is a potent bactericidal agent that inhibits RNA synthesis?

Accepted Answer

Rifampicin

Answer

Pyrazinamide

Answer

Ethambutol

Answer

PAS

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?